Browse by author
Lookup NU author(s): Dr Kenneth RankinORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018 Wiley Periodicals, Inc. Osteosarcoma is the most common type of primary malignant bone tumor in children and young adults. Development of clinically useful biomarkers has the potential to improve treatments. The aim of this review was to investigate the recent literature assessing the utility of biomarkers for osteosarcoma. A detailed literature search was performed, with hand searches for related research publications. The search was limited to publications in English between January 2007 and February 2017. Of 286 studies identified, 24 met the inclusion criteria. There is a wide range of osteosarcoma biomarkers identified which act as clinical prognostic factors in patient outcome.
Author(s): Tan GJS, Gerrand CH, Rankin KS
Publication type: Article
Publication status: Published
Journal: Pediatric Blood and Cancer
Print publication date: 01/01/2019
Online publication date: 24/09/2018
Acceptance date: 30/08/2018
ISSN (print): 1545-5009
ISSN (electronic): 1545-5017
Publisher: John Wiley and Sons Inc.
Altmetrics provided by Altmetric